BIOTECH TARGET N V - 24 May 2021 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role: 10%+ Owner
Signature: /s/ Ivo Betschart
Issuer symbol: ESPR
Transactions as of: 24 May 2021
Transactions value $: $2,021,620
Form type: 4
Filing time: 26 May 2021, 11:53:05 UTC
Previous filing: 21 May 2021
Next filing: 11 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ESPR	Common Stock	Purchase	$2.02M	+100K	+2.28%	$20.22	4.48M	24 May 2021	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Esperion Therapeutics, Inc. held directly or indirectly by Biotech Target N.V. This Form 4 is filed jointly by BB Biotech AG and Biotech Target N.V.